亲和VAE:一个多目标模型用于蛋白质 - 配体亲和力预测和药物设计
Mengying Wang1, Weimin Li1, Xiao Yu1
1School of Computer Engineering and Science, Shanghai University, Shanghai, China.
Computational biology and chemistry
|October 18, 2023
概括
这项研究介绍了AffinityVAE,这是一个新的深度学习模型,用于预测蛋白质 - 连接体亲和力. 它通过可解释的相互作用地图来提高预测准确性和数据多样性来增强药物发现.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 生物信息学是一种生物信息学.
背景情况:
- 传统的蛋白质 - 连接体亲和力预测方法是计算密集型的,并且难以处理结构变化.
- 数据驱动的深度学习方法提供了希望,但往往缺乏可解释性.
- 现有方法可能需要额外的领域知识或结构数据,限制其广泛适用性.
研究的目的:
- 开发一种可解释和高效的深度学习模型,用于蛋白质 - 配体亲和力预测.
- 在计算成本和可解释性方面解决当前方法的局限性.
- 通过改进的亲和预测和数据生成,增强药物发现管道.
主要方法:
- 拟议的Affinity变量自编码器 (AffinityVAE),是一个集成交互特征映射和变量自编码器的多目标模型.
- 引入了蛋白质 - 连接体相互作用特征图,以提高模型的解释性.
- 设计了一种适应性自编码器,用于化学特性,以生成多样化,新联体数据,扩大训练集.
主要成果:
- AffinityVAE展示了高预测性能,在效率和准确性方面表现优于最近的方法.
- 蛋白质-连接体相互作用特征图为亲和力预测中的可解释性提供了一种新的方法.
- 适应性自编码器成功地增加了蛋白质 - 配体结合数据的多样性和数量.
结论:
- AffinityVAE提供了一种强大,可解释和高效的解决方案,用于蛋白质 - 配体亲和力预测.
- 该模型具有显著的潜力,可以通过提高数据可用性和预测准确性来加速药物开发.
- 这项工作推动了深度学习与可解释方法在计算药物发现中的整合.
相关概念视频
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Affinity and Avidity
36.2K
Overview
36.2K
The Equilibrium Binding Constant and Binding Strength
13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
The Two-State Receptor Model
2.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.0K


